JP2003519164A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003519164A5 JP2003519164A5 JP2001549618A JP2001549618A JP2003519164A5 JP 2003519164 A5 JP2003519164 A5 JP 2003519164A5 JP 2001549618 A JP2001549618 A JP 2001549618A JP 2001549618 A JP2001549618 A JP 2001549618A JP 2003519164 A5 JP2003519164 A5 JP 2003519164A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- release
- polymer
- formulation
- dth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17413799P | 1999-12-31 | 1999-12-31 | |
| US60/174,137 | 1999-12-31 | ||
| PCT/US2001/000030 WO2001049249A2 (en) | 1999-12-31 | 2001-01-02 | Pharmaceutical formulation for regulating the timed release of biologically active compounds based on a polymer matrix |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003519164A JP2003519164A (ja) | 2003-06-17 |
| JP2003519164A5 true JP2003519164A5 (de) | 2011-04-28 |
Family
ID=22634986
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001549618A Pending JP2003519164A (ja) | 1999-12-31 | 2001-01-02 | ポリマーマトリクスに基づく生理活性化合物徐放調節用医薬製剤 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1263453A4 (de) |
| JP (1) | JP2003519164A (de) |
| AU (1) | AU784226B2 (de) |
| CA (1) | CA2396037A1 (de) |
| WO (1) | WO2001049249A2 (de) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7326425B2 (en) | 1999-12-31 | 2008-02-05 | Rutgers, The State University | Pharmaceutical formulation composed of a polymer blend and an active compound for time-controlled release |
| US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| CA2544678C (en) | 2003-11-05 | 2013-12-31 | Sunesis Pharmaceuticals, Inc. | Modulators of cellular adhesion |
| SI2444079T1 (sl) | 2005-05-17 | 2017-05-31 | Sarcode Bioscience Inc. | Sestavki in postopki za zdravljenje očesnih motenj |
| MX2008010126A (es) | 2006-02-08 | 2010-02-22 | Tyrx Pharma Inc | Protesis de malla temporalmente rigidizadas. |
| US8315700B2 (en) | 2006-02-08 | 2012-11-20 | Tyrx, Inc. | Preventing biofilm formation on implantable medical devices |
| US9265865B2 (en) | 2006-06-30 | 2016-02-23 | Boston Scientific Scimed, Inc. | Stent having time-release indicator |
| US9023114B2 (en) | 2006-11-06 | 2015-05-05 | Tyrx, Inc. | Resorbable pouches for implantable medical devices |
| WO2008127411A1 (en) | 2006-11-06 | 2008-10-23 | Tyrx Pharma, Inc. | Mesh pouches for implantable medical devices |
| CA2682190C (en) | 2007-03-29 | 2015-01-27 | Tyrx Pharma, Inc. | Biodegradable, polymer coverings for breast implants |
| EP2150119B1 (de) | 2007-05-02 | 2018-04-11 | Tyrx, Inc. | Dihydroxybenzoatpolymere und ihre verwendung |
| US20100120694A1 (en) | 2008-06-04 | 2010-05-13 | Synergy Pharmaceuticals, Inc. | Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
| CA3089569C (en) | 2007-06-04 | 2023-12-05 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| EP2209371B1 (de) | 2007-10-19 | 2017-01-04 | SARcode Bioscience Inc. | Zusammensetzungen und verfahren zur behandlung von diabetischer retinopathie |
| US8080562B2 (en) | 2008-04-15 | 2011-12-20 | Sarcode Bioscience Inc. | Crystalline pharmaceutical and methods of preparation and use thereof |
| WO2010006046A1 (en) | 2008-07-10 | 2010-01-14 | Tyrx Pharma, Inc. | Nsaid delivery from polyarylates |
| EP2321341B1 (de) | 2008-07-16 | 2017-02-22 | Synergy Pharmaceuticals Inc. | Zur behandlung von erkrankungen des magen-darm-trakts, entzündlichen erkrankungen, krebs und anderen erkrankungen geeignete agonisten von guanylatcyclase |
| CA2833960C (en) | 2008-09-22 | 2015-12-22 | Tyrx, Inc. | Linear polyesteramides from aminophenolic esters |
| US9839628B2 (en) | 2009-06-01 | 2017-12-12 | Tyrx, Inc. | Compositions and methods for preventing sternal wound infections |
| EP2437724B1 (de) * | 2009-06-01 | 2015-09-30 | Tyrx, Inc. | Zusammensetzungen und verfahren zur verhinderung von wundinfektionen im brustbein |
| EP2459638B1 (de) * | 2009-07-31 | 2017-09-27 | Rutgers, The State University of New Jersey | Monomere und daraus hergestellte phasengetrennte biokompatible polymerzusammensetzungen zur verwendung in der medizin |
| US8409279B2 (en) | 2009-10-01 | 2013-04-02 | Lipose Corporation | Breast implant implantation method and apparatus |
| WO2011050175A1 (en) | 2009-10-21 | 2011-04-28 | Sarcode Corporation | Crystalline pharmaceutical and methods of preparation and use thereof |
| EP3489313A1 (de) | 2010-08-25 | 2019-05-29 | Tyrx, Inc. | Neuartige beschichtungen für medizinische vorrichtung |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| AU2011326417A1 (en) | 2010-11-12 | 2013-05-09 | Tyrx, Inc. | Anchorage devices comprising an active pharmaceutical ingredient |
| AU2012283875B2 (en) | 2011-07-20 | 2016-05-12 | Medtronic, Inc. | Drug eluting mesh to prevent infection of indwelling transdermal devices |
| US9085553B2 (en) | 2012-07-25 | 2015-07-21 | SARcode Bioscience, Inc. | LFA-1 inhibitor and methods of preparation and polymorph thereof |
| JP6499591B2 (ja) | 2013-02-25 | 2019-04-10 | シナジー ファーマシューティカルズ インコーポレイテッド | 結腸洗浄において用いるためのグアニル酸シクラーゼ受容体アゴニスト |
| WO2014137454A1 (en) | 2013-03-07 | 2014-09-12 | Tyrx, Inc. | Methods and compositions to inhibit the assemblage of microbial cells irreversibly associated with surfaces of medical devices |
| EP2970384A1 (de) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Agonisten der guanylatcyclase und deren verwendungen |
| JP2016514670A (ja) | 2013-03-15 | 2016-05-23 | シナジー ファーマシューティカルズ インコーポレイテッド | 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト |
| US20160220630A1 (en) | 2013-10-10 | 2016-08-04 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of opioid induced dysfunctions |
| EP3065788A1 (de) | 2013-11-08 | 2016-09-14 | Tyrx, Inc. | Antimikrobielle zusammensetzungen und verfahren zur verhütung von infektionen in chirurgischen einstichstellen |
| WO2016020308A1 (en) * | 2014-08-04 | 2016-02-11 | Janssen Sciences Ireland Uc | Compacted solid dosage form |
| EP3402804A1 (de) | 2016-01-11 | 2018-11-21 | Synergy Pharmaceuticals Inc. | Formulierungen und verfahren zur behandlung von colitis ulcerosa |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5587507A (en) * | 1995-03-31 | 1996-12-24 | Rutgers, The State University | Synthesis of tyrosine derived diphenol monomers |
| US5658995A (en) * | 1995-11-27 | 1997-08-19 | Rutgers, The State University | Copolymers of tyrosine-based polycarbonate and poly(alkylene oxide) |
| US6120491A (en) * | 1997-11-07 | 2000-09-19 | The State University Rutgers | Biodegradable, anionic polymers derived from the amino acid L-tyrosine |
| JP4410857B2 (ja) * | 1997-02-18 | 2010-02-03 | ラットガーズ ザ ステイト ユニヴァーシティ | ヒドロキシ酸から誘導されたモノマー及びそれから調製されたポリマー |
| DE19719817A1 (de) * | 1997-05-13 | 1998-11-19 | Hoechst Ag | Substituierte 6- und 7-Aminotetrahydroisochinolincarbonsäuren |
| US6267987B1 (en) * | 1997-12-12 | 2001-07-31 | Samyang Corporation | Positively charged poly[alpha-(omega-aminoalkyl) glycolic acid] for the delivery of a bioactive agent via tissue and cellular uptake |
| US20020151668A1 (en) * | 1998-04-13 | 2002-10-17 | Ken James | Construction of copolymer libraries |
| EP1157421A1 (de) * | 1999-02-05 | 2001-11-28 | Alien Technology Corporation | Verfahren und vorrichtungen zum herstellen von baugruppen |
-
2001
- 2001-01-02 EP EP01939971A patent/EP1263453A4/de not_active Ceased
- 2001-01-02 AU AU29255/01A patent/AU784226B2/en not_active Expired
- 2001-01-02 CA CA002396037A patent/CA2396037A1/en not_active Abandoned
- 2001-01-02 WO PCT/US2001/000030 patent/WO2001049249A2/en active Application Filing
- 2001-01-02 JP JP2001549618A patent/JP2003519164A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003519164A5 (de) | ||
| Bose et al. | Biodegradable polymers for modern vaccine development | |
| US4942035A (en) | Continuous release formulations | |
| TWI250028B (en) | Biodegradable ph/thermosensitive hydrogel for sustained delivery of biologically active agents | |
| Gombotz et al. | Protein release from alginate matrices | |
| US5529777A (en) | Hydrogel microencapsulated vaccines | |
| US4863735A (en) | Biodegradable polymeric drug delivery system with adjuvant activity | |
| US4882168A (en) | Polyesters containing alkylene oxide blocks as drug delivery systems | |
| Kissel et al. | Parenteral protein delivery systems using biodegradable polyesters of ABA block structure, containing hydrophobic poly (lactide-co-glycolide) A blocks and hydrophilic poly (ethylene oxide) B blocks | |
| CA1288344C (en) | Drug delivery system | |
| EP2316490A3 (de) | Verfahren und Formulierungen zur verbesserten Abgabe von bioaktiven Molekülen | |
| JP2007308500A (ja) | Ｇｍ−ｃｓｆの放出の延長 | |
| CA2203857A1 (en) | Microparticles for delivery of nucleic acid | |
| PT863933E (pt) | Novos hidrogeis a base de copolimeros de bloco com res sequencias sua preparacao e sua aplicacao | |
| NZ204643A (en) | Controlled release device containing polymer and acid anhydride | |
| KR20090086478A (ko) | 약물 전달을 위한 생분해가능 블록 공중합성 조성물 | |
| EP0258780A2 (de) | Alkylenoxydblöcke enthaltende Polyester und deren Verwendung als Arzneimittelabgabesysteme | |
| CN101331173A (zh) | 生物相容性嵌段共聚物、其用途和制造方法 | |
| CA2424936A1 (en) | Vaccine composition comprising an immunologically active substance embedded in microparticles consisting of starch with reduced molecular weight | |
| CA2167081A1 (en) | Hydrogel microencapsulated vaccines | |
| WO1995002416A9 (en) | Hydrogel microencapsulated vaccines | |
| CN1446833A (zh) | 一种温敏性可降解微凝胶及其制备方法 | |
| Ghahremankhani et al. | PLGA-PEG-PLGA tri-block copolymers as an in-situ gel forming system for calcitonin delivery | |
| AL et al. | Biodegradable polymers: Which, when and why? | |
| JP2013536177A (ja) | ２−ヒドロキシアルキル酸から調製されたポリマーを含む組成物 |